Streetbeat News

Stock Prices

ZOM

Zomedica reported Q1 2024 GAAP EPS of $(0.01), a 42.86% decrease from last year, with sales of $6.262M missing the $8.184M estimate, yet marking a 14.23% increase YoY.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:25 pm

PDFS

PDF Solutions (NASDAQ:PDFS) reported Q1 2024 adjusted EPS of $0.15, meeting analyst estimates, with a 21.05% decrease from the previous year. Sales reached $41.310M, exceeding estimates by 1.34% and marking a 1.35% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:24 pm

ORGO

Organogenesis Holdings (ORGO) reported Q1 2024 adjusted EPS of $(0.01), surpassing the $(0.03) estimate, with sales of $109.976M exceeding the $101.050M forecast. This represents a 2.17% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:24 pm

CDNA

CareDx forecasts its FY24 revenue to be between $274M and $282M, surpassing the estimated $266.955M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:24 pm

EGAN

eGain (NASDAQ:EGAN) reported Q3 2024 adjusted EPS of $0.08, surpassing the $0.07 estimate, marking a 166.67% increase from last year. However, sales of $22.350M fell short of the $22.806M estimate, a 2.88% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:23 pm

KNTK

Kinetik Holdings Inc. (KNTK) has announced a series of strategic transactions including the acquisition of Durango Permian LLC for $765 million in cash and equity, a new 15-year service agreement in Eddy County, New Mexico, and the sale of its 16% stake in the Gulf Coast Express pipeline (GCX) for $540 million. These moves aim to expand Kinetik's operations in the Permian Basin, doubling its pipeline mileage and processing capacity, and adding over 60 new customers. The transactions are expected to be over 10% accretive to Kinetik's free cash flow per share starting in the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:22 pm

GAN

GAN reported a Q1 2024 GAAP EPS of $(0.09), down from $0.03 YoY, with sales of $30.651M missing the $39.951M estimate, marking a 23.28% miss and a 12.75% decrease in sales YoY.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:19 pm

TLLTF

TILT Holdings Inc. (OTC:TLLTF) has entered into a financing agreement to expand its subsidiary, Standard Farms, in Pennsylvania. The deal allows borrowing up to $10.5 million with escalating interest rates starting at 20%, aimed at constructing dispensaries under a new permit. This strategic move is expected to strengthen TILT's market position in Pennsylvania, a state showing resilience in cannabis sales despite broader market downturns. TILT's financials indicate a leveraged but manageable position, with a need to address liquidity challenges.

Portfolio Pulse from Nicolás Jose Rodriguez

May 09, 2024 | 9:19 pm

CTSO

CytoSorbents (NASDAQ:CTSO) reported Q1 2024 GAAP EPS of $(0.12), meeting analyst estimates and marking a 29.41% improvement from last year's $(0.17) per share. Sales reached $9.787M, slightly above the $9.785M forecast, representing a 3.58% year-over-year increase.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:19 pm

CPHC

Canterbury Park Holding (NASDAQ:CPHC) reported a significant decrease in Q1 EPS to $0.20 from $0.56 YoY, despite a 6.00% increase in sales to $14.10M from $13.30M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 9:16 pm